TITLE

BONE MEDICAL GETS U.S. FDA GUIDANCE ON IND FOR CAPSITONIN

PUB. DATE
October 2009
SOURCE
Worldwide Biotech;Oct2009, Vol. 21 Issue 10, p2
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports that a formal response was received by the Bone Medical from the U.S. Food and Drug Administration regarding the Investigational New Drug (IND) application for the approved osteoporosis drug salmon calcitonin. The response indicates that Bone Medical now has an open IND and identifies pathway the company can undertake which includes a 12-month Phase III study.
ACCESSION #
44276415

 

Related Articles

  • FDA approves GM salmon. POLLACK, ANDREW // Aquatic Veterinarian;2015 4th Quarter, Vol. 9 Issue 4, p40 

    The article discusses approval of the AquaBounty Technologies' AquAdvantage salmon for human consumption by the Food and Drug Administration (FDA) and also mentions that the approval has been opposed by some consumer and environmental group.

  • Denosumab Receives Conditional Approval from FDA Expert Panel.  // Critical Care Alert;Oct2009 Pharmacology, p2 

    The article reports that denosumab has received conditional approval from the U.S. Food and Drug Administration (FDA) Expert Panel as treatment for osteoporosis.

  • Osteoporosis and fracture prevention.  // Geriatrics;Jul97, Vol. 52 Issue 7, p20 

    Announces the approval of the US Food and Drug Administration for the use of the drug `alendronate sodium (Fosamax)' for the prevention of osteoporosis and fractures of the hip, wrist and spine in postmenopausal women. Recommended dose for the prevention of osteoporosis; Common adverse events...

  • Osteoporosis.  // MidLife Woman;Dec95, Vol. 4 Issue 6, p9 

    Focuses on new products approved by the US Food and Drug Administration for treatment of osteoporosis. Fosamax oral alendronate; Miacalcin Nasal Spray.

  • First nonhormonal for osteoporosis.  // Modern Medicine;Nov95, Vol. 63 Issue 11, p35 

    Reports that the Food and Drug Administration (FDA) has cleared the drug, alendronate sodium which is used for osteoporosis for marketing. What the drug is used for; Labeling cautions; Side effects.

  • New device diagnoses osteoporosis without x-rays.  // FDA Consumer;Jul/Aug98, Vol. 32 Issue 4, p6 

    Reports on the approval of an ultrasound device by the United States Food and Drug Administration on March 12, 1998. Benefits of this device to physicians' diagnosis of osteoporosis and assessment of risk of bone fracture; Manufacturer of the Sahara Clinical Bone Sonometer; Information on...

  • FDA Approves Genetically Engineered Salmon.  // New American (08856540);12/21/2015, Vol. 31 Issue 24, p6 

    The article focuses on an approval passed by the Food and Drug Administration (FDA) on the consumption of genetically modified sea fish salmon as safe for the human body.

  • FDA Approves First GE Animal.  // SN: Supermarket News;10/17/2011, Vol. 59 Issue 42, p20 

    The article offers information on the approval of the first genetically engineered salmon meant for human consumption, by the U.S. Food and Drug Administration (FDA).

  • Dems urge FDA to reject modified salmon. Lillis, Mike // Hill;9/30/2010, Vol. 17 Issue 107, p18 

    The article reports that Democrats in the U.S. have encouraged the country's Food and Drug Administration (FDA) to reject a company's bid to bring a genetically modified salmon to market.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics